S100A9 and Patent ductus arteriosus: S100A9 is a calcium- and zinc-binding protein with a key function in regulating inflammation and immune responses, and has been previously associated with PDA inflammation status, invasiveness, and metastasis [25,35]; in our experimental setting, S100A9 levels increased in case of worst prognosis.